IL6 and Parkinson disease: Activation of microglial and astrocytes has been well-documented in PD, leading to the release of proinflammatory cytokines/mediators, interleukin-6 (IL-6), interleukin-1β (IL-1β), tumor necrosis factor-alpha (TNF-α), and oxygen free radicals [4].